Viewing data from:

LEVONEST

ANDA

ETHINYL ESTRADIOL; LEVONORGESTREL | A090719 | NOVAST LABORATORIES LTD

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Levonest (2023)

Total Spending

$12K

Total Claims

457

Beneficiaries

Avg Cost/Unit

$0.57

Spending Trend

$22K(2019)→$21K(2020)→$19K(2021)→$16K(2022)→$12K(2023)

YoY Change:-7.4%

5yr CAGR:-1.3%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.03MG,0.04MG,0.03MG;0.05MG,0.075MG,0.125MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Dec 29, 2010

No patent or exclusivity listings for this strength.